Press release content from Business Wire. The AP news staff was not involved in its creation.
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity
February 11, 2021 GMT
CAMBRIDGE, Mass. (BUSINESS WIRE) Feb 11, 2021
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year ended December 31, 2020 and reviewed recent business highlights.
“We’re very pleased with the 2020 commercial performance for our marketed products, and expect steady and continued growth in 2021 across our product portfolio, driven by improved disease awareness, new patient finding, and geographic expansion. In the fourth quarter we celebrated the regulatory approvals of our third and fourth commercial medicines: OXLUMO, in the EU and U.S.; and Leqvio, in the EU. We also reported positive topline results from the HELIOS-A Pha
Press release content from Business Wire. The AP news staff was not involved in its creation.
Middle East Media and Entertainment Market Growth, Trends, and Forecasts Report 2021-2026 - ResearchAndMarkets.com
February 11, 2021 GMT
DUBLIN (BUSINESS WIRE) Feb 11, 2021
ResearchAndMarkets.com’s offering.
The Middle Eastern media and entertainment market was valued at USD 35.11 billion in 2020, and expected to reach USD 69.83 Billion by 2026 and grow at a CAGR of 12.79% over the forecast period (2021 - 2026).
ADVERTISEMENT
Growing trends around personalization and increased digitalization, significant growth in online Gaming, OTT, and internet advertising are some of the major factors driving the growth of the market. The use of social media is growing across Saudi Arabia, a trend of interest to brands, agencies, and media companies alike for advertisements.
MELBOURNE, Australia — Australia’s second-largest city will begin its third lockdown due to a rapidly spreading COVID-19 cluster centered on hotel quarantine.
Press release content from Business Wire. The AP news staff was not involved in its creation.
The AZEK Company Announces First Quarter Fiscal Year 2021 Financial Results
February 11, 2021 GMT
CHICAGO (BUSINESS WIRE) Feb 11, 2021
The AZEK Company Inc. (the “Company” or “AZEK”) (NYSE: AZEK), an industry-leading manufacturer of beautiful, low-maintenance and sustainable residential and commercial building products, today announced financial results for the first quarter ended December 31, 2020 of its fiscal year 2021.
CEO COMMENTS
“Demand trends have continued their momentum, enabling us to deliver strong first quarter sales growth as well as increased confidence in our outlook for the remainder of the year,” commented Jesse Singh, AZEK’s Chief Executive Officer. “Our team continues to do an excellent job of executing against our key strategic initiatives, including new product launches as well as our capacity expansion and recycling programs, which is evident in
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a .
BioXcel TherapeuticsFebruary 12, 2021 GMT
NEW HAVEN, Conn., Feb. 12, 2021 (GLOBE NEWSWIRE) BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that the Company will host a virtual Key Opinion Leader (“KOL”) event on Friday, February 19, 2021 from 11:00 am ET to 2:00 pm ET. The event aims to highlight BXCL501, the Company’s investigational, proprietary, orally dissolving thin film formulation of dexmedetomidine (“Dex”), and its potential as a treatment option for multiple neuropsychiatric conditions.